Tumor necrosis factor-α stimulates prostaglandin F2α secretion by bovine luteal cells via activation of mitogen-activated protein kinase and phospholipase A2 pathways

Molecular Reproduction and Development

Volumn 56, Issue 3, 2000, Pages 387-391

  Sakumoto, Ryosuke ^a   Murakami, Shuko ^a   Okuda, Kiyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Corpus luteum; MAP kinase; Phospholipase A2; Prostaglandin F2 ; TNF

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALPHOSTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C INHIBITOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; ENZYME ACTIVATION; ENZYME INHIBITOR COMPLEX; FEMALE; IMMUNOSTIMULATION; LUTEAL CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; CELLS, CULTURED; CORPUS LUTEUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROST; ENZYME INHIBITORS; ESTRENES; FEMALE; HUMANS; ISOQUINOLINES; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHALENES; PHOSPHOLIPASE C; PHOSPHOLIPASES A; PROTEIN KINASE C; PYRROLIDINONES; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0034040892     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2795(200007)56:3<387::AID-MRD9>3.0.CO;2-A     Document Type: Article

References (36)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Baker SJ, Kerppola TK, Luk D, Vanderberg MT, Marshak DR, Curran T, Abate C. 1992. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts. Mol Cell Biol 12:4694-4705.
3. Benyo DF, Pate JL. 1992. Tumor necrosis factor-α alters bovine luteal cell synthetic capacity and viability. Endocrinology 130:854-860.
4. Beutler B, van Huffel C. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667-668.
5. Brunswig-Spickenheier B and Mukhopadhyay AK. 1997. Stimulation of nitric oxide-cyclic guanosine monophosphate (cGMP) pathway in bovine ovarian theca cells by tumor necrosis factor α (TNFα): is this pathway implicated in the TNFα-induced inhibition of luteinizing hormone (LH)-stimulated prorenin production? Biol Reprod 57:700-706.
6. Chen DB, Westfall SD, Fong HW, Roberson MS, Davis JS. 1998. Prostaglandin F2α stimulates the Raf/MEK1/Mitogen-activated protein kinase signaling cascade in bovine luteal cells. Endocrinology 139:3876-3885.
7. Chen RH, Sarnecki C, Blenis J. 1992. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol 12:915-927.
8. Clark MA, Chen MJ, Crooke ST, Bomalaski JS. 1988. Tumour necrosis factor (cachectin) induces activity and synthesis of phospholipase A2-activating protein in endothelial cells. Biochem J 250:125-132.
9. Cobb MH, Goldsmith EJ.1995. How MAP kinases are regulated. J Biol Chem 270:14843-14846.
10. Davies MG, Fulton GJ, Hagen PO. 1995. Clinical biology of nitric oxide. Br J Surg 82:1598-1610.
11. Gupta S, Davis RJ. 1994. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett 353:281-285.
12. Ireland JJ, Murphee RL, Coulson PB. 1980. Accuracy of predicting stages of bovine estrous cycle by gross appearance of the corpus luteum. J Dairy Sci 63:155-160.
13. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
14. Liu L. 1999. Regulation of lung surfactant secretion by phospholipase A2. J Cell Biochem 72:103-110.
15. Miyamoto Y, Skarzynski DJ, Okuda K. 2000. Is tumor necrosis factor-α a trigger for the initiation of endometrial prostaglandin F2α release at luteolysis in cattle? Biol Reprod 62:(in press).
16. Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
17. Motta AB, Gimeno MA. 1997. Nitric oxide participates in corpus luteum regression in ovaries isolated from pseudopregnant rats. Can J Physiol Pharmacol 75:1335-1339.
18. Motta AB, Franchi AM, Gimeno MF. 1997. Role of nitric oxide on uterine and ovarian prostaglandin synthesis during luteolysis in the rat. Prostaglandins Leukot Essential Fatty Acids 56:265-269.
19. Muller G, Storz P, Bourteele S, Doppler H, Pfizenmaier K, Mischak H, Philipp A, Kaiser C, Kolch W. 1998. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signaling. EMBO J 17:732-742.
20. Novaro V, Rettori V, Gonzalez ET, Jawerbaum A, Faletti A, Canteros G, de Gimeno MA. 1996. Interaction between uterine PGE2 and PGF2α production and the nitridergic system during embryonic implantation in the rat. Prostaglandins 51:363-376.
21. Okuda K, Kito S, Sumi N, Sato K. 1988. Study of the central cavity in the bovine corpus luteum. Vet Rec 123:180-183.
22. Okuda K, Miyamoto A, Sauerwein H, Schweigert FJ, Schams D. 1992. Evidence for oxytocin receptors in cultured bovine luteal cells. Biol Reprod 46:1001-1006.
23. Pang L, Sawada T, Decker SJ, Saltiel AR. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
24. Pyne NJ, Tolan D, Pyne S. 1997. Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle. Biochem J 328:689-694.
25. Sa G, Murugesan G, Jaye M, Ivashchenko Y, Fox PL. 1995. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270:2360-2366.
26. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Deedlman P. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244.
27. Sakumoto R, Berisha B, Kawate N, Schams D, Okuda K. 2000. Tumor necrosis factor-α and its receptor in bovine corpus luteum throughout the estrous cycle. Biol Reprod 62:192-199.
28. Tartaglia LA, Goeddel DV. 1992. Two TNF receptors. Immunol Today 13:151-153.
29. Terranova PF. 1997. Potential roles of tumor necrosis factor-α in follicular development, ovulation, and the life span of the corpus luteum. Dom Anim Endocrinol 14:1-15.
30. Townson DH, Pate JL. 1996. Mechanism of action of TNF-alpha-stimulated prostaglandin production in cultured bovine luteal cells. Prostaglandins 52:361-373.
31. Uenoyama Y, Hattori S, Miyake M, Okuda K. 1997. Up-regulation of oxytocin receptors in porcine endometrium by adenosine 3′,5′-monophosphate. Biol Reprod 57:723-728.
32. ras-GTP complex and mitogen-activated protein kinase in NIH-3T3 cells via Gq-protein-coupled pathway. J Biol Chem 270:8984-8990.
33. Xu XS, Vanderziel C, Bennett CF, Monia BP. 1998. A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules. J Biol Chem 273:33230-33238.
34. Zachow R, Terranova P. 1993. Involvement of protein kinase C and protein tyrosine kinase pathways in tumor necrosis factor-α induced clustering of ovarian theca-interstitial cells. Mol Cell Endocrinol 97:37-49.
35. Zachow R, Tash J, Terranova P. 1993. Tumor necrosis factor-α attenuation of luteinizing hormone-stimulated androstenedione production by ovarian theca-intestitial cells: inhibition at loci within the adenosine 3',5'-monophosphate-dependent signaling pathway. Endocrinology 133:2269-2276.
36. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89:63-72.